FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
PosttranslationalModification
|
disease |
BEFREE |
To assess the 5' CpG island methylation of Fanconi anemia, complementation group F (FANCF) gene in epithelial ovarian cancer (EOC) tissues and normal ovarian tissues and to investigate the relationship between FANCF methylation and clinicopathologic features and prognosis of EOC.
|
26507869 |
2016 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
CausalMutation
|
disease |
CLINVAR |
Clinical aspects of Fanconi anemia individuals with the same mutation of FANCF identified by next generation sequencing.
|
26033879 |
2015 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
Biomarker
|
disease |
BEFREE |
Fanconi anemia complementation group-F (FANCF) is a key factor to maintain the function of FA/BRCA, a DNA-damage response pathway.
|
22952942 |
2012 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
How the fanconi anemia pathway guards the genome.
|
19686080 |
2009 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
GeneticVariation
|
disease |
CLINVAR |
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.
|
16084127 |
2005 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
CausalMutation
|
disease |
CLINVAR |
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients.
|
16084127 |
2005 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
CausalMutation
|
disease |
CLINVAR |
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM.
|
10615118 |
2000 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM.
|
10615118 |
2000 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
GeneticVariation
|
disease |
CLINVAR |
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM.
|
10615118 |
2000 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Evidence for at least eight Fanconi anemia genes.
|
9382107 |
1997 |
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
Biomarker
|
disease |
CTD_human |
|
|
|
FANCONI ANEMIA, COMPLEMENTATION GROUP F
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
leukemia
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
Leukemia, Myelocytic, Acute
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Germline Genetic Predisposition to Hematologic Malignancy.
|
28297620 |
2017 |
leukemia
|
0.510 |
Biomarker
|
disease |
BEFREE |
Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
|
25647473 |
2015 |
Leukemia, Myelocytic, Acute
|
0.510 |
Biomarker
|
disease |
BEFREE |
Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.
|
14617007 |
2003 |
leukemia
|
0.510 |
CausalMutation
|
disease |
CGI |
|
|
|
Leukemia, Myelocytic, Acute
|
0.510 |
CausalMutation
|
disease |
CGI |
|
|
|
Fanconi Anemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
It is the first report of a mutation in the FANCF gene in Iranian patients with Fanconi anemia.
|
31288759 |
2019 |
Fanconi Anemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Many had mutations in Fanconi anemia complex genes [BRCA2 (3 participants), FANCF, FANCM].
|
28687971 |
2018 |
Fanconi Anemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Currently, information on the phenotypic findings of patients with Fanconi anemia from biallelic mutations in FANCF is limited.
|
27714961 |
2017 |
Fanconi Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The Fanconi anemia (FA)‑associated proteins FANCF and FANCD2 are important components of the FA pathway of DNA crosslink repair.
|
25647473 |
2015 |
Fanconi Anemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Clinical aspects of Fanconi anemia individuals with the same mutation of FANCF identified by next generation sequencing.
|
26033879 |
2015 |
Fanconi Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
We found that silencing of FANCF inactivated the FA/BRCA pathway by decreasing the monoubiquitination and focus formation of FANCD2 and reduced the function of the FA/BRCA pathway, resulting in the inhibition of cell proliferation, increased cell apoptosis and DNA damage in OVCAR3 cells.
|
23440494 |
2013 |
Fanconi Anemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Six small molecules, including bortezomib (proteasome inhibitor), CA-074-Me (cathepsin B inhibitor) and 17-AAG (HSP90 inhibitor), synergized with cisplatin specifically in FA-proficient ovarian cancer cells (2008 + FANCF), but not in FA-deficient isogenic cells (2008).
|
22537224 |
2012 |